Internet-CBT for Gambling Disorder - a Randomized Controlled Trial

Last updated: March 6, 2024
Sponsor: Karolinska Institutet
Overall Status: Active - Recruiting

Phase

N/A

Condition

Gambling Problems

Treatment

Internet-based cognitive behavioral therapy (iCBT)

Clinical Study ID

NCT06099522
Dnr 2023-01075-01
  • Ages > 18
  • All Genders

Study Summary

The study is a randomized controlled trial (Total N=150; each condition n=75) of internet-based cognitive behavioral therapy (iCBT), with measures at pre, weekly during treatment, post, three and at six month follow-up. Participants will be assigned to either standard iCBT and "Spelpaus" (treatment condition), or "Spelpaus" only (control condition).

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Screen positive for GD, as measured with the Gambling Disorder Identification Test (total score ≥20 GDIT).
  • Fulfilling GD, assessed according to the Structured Clinical Interview for GamblingDisorder (SCI-GD).
  • Utilization of "Spelpaus", 3 months from treatment start.
  • ≥18 years of age.
  • Able to provide digital informed consent.

Exclusion

Exclusion Criteria:

  • Other ongoing psychological treatment for GD.
  • Severe depression, screened according to the Montgomery Åsberg Depression Rating Scale (total score >34 MADRS-S).
  • Suicidality, screening of ≥4 points on item 9 of the MADRS-S

Study Design

Total Participants: 150
Treatment Group(s): 1
Primary Treatment: Internet-based cognitive behavioral therapy (iCBT)
Phase:
Study Start date:
January 15, 2024
Estimated Completion Date:
June 01, 2025

Study Description

Recruitment will be done through online advertisement via social media and gambling-related websites. Participants will self-referred to the study via a study dedicated website (www.spelstudien.se). Login to a treatment platform will be verified using double authentication (detailed description of the online platform is provided in the application to the Swedish Ethical Review Authority). Written information about the study will be provided on the web page. Consent will be done online, with the possibility for participants to download study information and consent. Consenting participants will start a screening procedure. After screening, participants will be contacted for a telephone assessment with a clinical psychologist. During this interview, participants will be assessed for GD with a diagnostic interview, as well as the inclusion criteria for utilization of "Spelpaus". If meeting criteria for the study, participants will be referred to the baseline/pre-measures - which will start with an additional informed consent for the treatment phase and the iCBT. Inclusion will be done after the completion of the informed consent and baseline/pre-measures. After that, participant will be randomized to iCBT and "Spelpaus" (treatment condition), or "Spelpaus" only (control condition). Randomization will be conducted by a third party using a true random service, https://random.org. Participants assigned to the control condition in the randomized controlled trial will receive a voucher of total 1000 Swedish Krona's when completing the post and follow up measures. Participants assigned to the control condition in the randomized controlled trial will receive a voucher of total 1000 Swedish Krona's when completing the post and follow up measures.

Connect with a study center

  • Centre for psychiatry research

    Stockholm, 116 30
    Sweden

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.